
Is ERCP-BD or EUS-BD the preferred decompression modality for malignant distal biliary obstruction? A meta-analysis of randomized controlled trials
Author(s) -
Defeng Li,
Chunhua Zhou,
Lisheng Wang,
Jun Yao,
Duowu Zou
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6125/2018
Subject(s) - medicine , endoscopic retrograde cholangiopancreatography , endoscopic ultrasound , adverse effect , confidence interval , randomized controlled trial , stent , cochrane library , radiology , gastroenterology , surgery , pancreatitis
endoscopic retrograde cholangiopancreatography (ERCP)-guided biliary drainage (ERCP-BD) with transpapillary stent placement is the standard palliative treatment for malignant distal biliary obstruction. Endoscopic ultrasound-guided biliary drainage (EUS-BD) has been evaluated for efficacy and safety as an alternative for failed ERCP.